[Interventional occlusion of foramen ovale and atrial septal defects after paradoxical embolism incidents]
- PMID: 12448068
- DOI: 10.1007/s00392-002-0835-x
[Interventional occlusion of foramen ovale and atrial septal defects after paradoxical embolism incidents]
Abstract
Two hundred and fifty-one patients with a persistent foramen ovale (PFO), mean age 43.3 +/- 12.4 years, underwent catheter closure between 6/1995 and 6/2001. One hundred and forty-one had an ischemic stroke, 99 a transient ischemic attack (TIA) or prolonged reversible ischemic neurologic deficit, 5 peripheral arterial embolism, 4 suffered from decompression sickness after diving and 2 had transient global amnesia. Fifty-nine of them had multiple events in spite of antiplatelet or anticoagulant therapy. The patients received five different devices: 13 Rashkind Occluders, 20 Amplatzer septal Occluders, 109 Amplatzer PFO-Occluders, 73 CardioSEAL and 36 STAR-Flex devices. Time of fluoroscopy was 8.3 +/- 4.5 min. In three patients a device embolized and had to be removed from the groin vessels. We saw five inguinal or retroperitoneal venous hematomas with the need for operation in one patient. One early and one late perforation of the left atrium caused by a guide wire and a left-atrial disc, respectively, also needed surgery. Fourteen patients had documented late arrhythmias. Six patients with atrial fibrillation needed drugs or cardioversion while the other patients with runs of supraventricular tachycardia, atrial flutter and multiple extrasystoles needed no therapy. On transesophageal echocardiography (TEE) 6 months after implantation we found four significant residual leaks. These patients had the defect closed with a second device. In addition a secundum atrial septal defect (ASD) was closed in 17 patients (mean age 38 +/- 10.5 years) with Amplatzer septal Occluders (12) and CardioSEAL devices (5). These patients had experienced eight strokes and nine TIAs, 3 of them had had multiple events. Two of these patients had a significant residual defect and one had atrial flutter following the procedure. Two hundred and two PFO-patients and 12 ASD patients were followed for 6-62 (24.6 +/- 14.2) months; 2 died due to a traffic accident and a myocardial infarction, respectively. Four patients had another neurologic event following PFO-closure. We now overlook 210 patients with 348.6 symptom-free patient years and have a 1-year recurrence rate of neurologic events of 1.9%. Catheter closure of the PFO and atrial septal defect is a simple, effective and quick method which ensures a high closure rate, avoids life-long anticoagulation and has a low recurrence rate of neurologic events.
Similar articles
-
Catheter closure of the persistent foramen ovale: mid-term results in 162 patients.J Interv Cardiol. 2001 Apr;14(2):223-9. doi: 10.1111/j.1540-8183.2001.tb00740.x. J Interv Cardiol. 2001. PMID: 12053310
-
Patent foramen ovale closure in patients with transient ischemia attack/stroke.J Interv Cardiol. 2001 Apr;14(2):261-6. doi: 10.1111/j.1540-8183.2001.tb00745.x. J Interv Cardiol. 2001. PMID: 12053315
-
AMPLATZER Septal Occluder failure resulting in paradoxical cerebral embolism.Tex Heart Inst J. 2012;39(5):647-52. Tex Heart Inst J. 2012. PMID: 23109759 Free PMC article. Review.
-
Transcatheter Amplatzer device closure of atrial septal defect and patent foramen ovale in patients with presumed paradoxical embolism.Mayo Clin Proc. 2004 Jan;79(1):35-41. doi: 10.4065/79.1.35. Mayo Clin Proc. 2004. PMID: 14708946
-
Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients.J Am Coll Cardiol. 2004 Jan 21;43(2):302-9. doi: 10.1016/j.jacc.2003.10.030. J Am Coll Cardiol. 2004. PMID: 14736453 Review.
Cited by
-
First experience with the 2005 modified Gore Helex ASD occluder system.Clin Res Cardiol. 2006 Sep;95(9):468-73. doi: 10.1007/s00392-006-0413-8. Epub 2006 Jul 20. Clin Res Cardiol. 2006. PMID: 16845573
-
Transhepatic approach of patent foramen ovale closure in the setting of congenital inferior vena cava anomaly.Clin Case Rep. 2024 Mar 8;12(3):e8653. doi: 10.1002/ccr3.8653. eCollection 2024 Mar. Clin Case Rep. 2024. PMID: 38464577 Free PMC article.
-
Hypoxemia from right-to-left shunting through a patent foramen ovale in right ventricular infarction: treatment by revascularization, preload reduction, and, finally, interventional PFO closure.Clin Res Cardiol. 2006 Dec;95(12):680-4. doi: 10.1007/s00392-006-0442-3. Epub 2006 Sep 28. Clin Res Cardiol. 2006. PMID: 16998741 No abstract available.
-
Occlusion of functional high-volume intra-atrial shunts in older patients after embolic stroke of undetermined source.Front Cardiovasc Med. 2024 Sep 27;11:1402137. doi: 10.3389/fcvm.2024.1402137. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39399510 Free PMC article.
-
Clinical evaluation of a novel occluder device (Occlutech) for percutaneous transcatheter closure of patent foramen ovale (PFO).Clin Res Cardiol. 2008 Dec;97(12):872-7. doi: 10.1007/s00392-008-0699-9. Epub 2008 Aug 11. Clin Res Cardiol. 2008. PMID: 18696022 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources